HOME › DRUGS › ERYTHROMYCIN STEARATE
ACTIVE SUBSTANCE / INN

ERYTHROMYCIN STEARATE

Brand name(s): ERYPAR, WYAMYCIN S, ERYTHROMYCIN STEARATE, ETHRIL 250, BRISTAMYCIN, ERYTHROCIN STEARATE, PFIZER-E, ETHRIL 500
FDA LISTED
DISCONTINUED
ANDA061675
ANDA062322
ACTIVE SUBSTANCE
Erythromycin Stearate
REGULATORS
FDA
SPONSORS / MAH
WYETH AYERST, AZURITY, BRISTOL MYERS SQUIBB
TOTAL APPLICATIONS
8
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ETHRIL 250ANDA061605BRISTOL MYERS SQUIBBDiscontinued
ETHRIL 500ANDA061605BRISTOL MYERS SQUIBBDiscontinued
WYAMYCIN SANDA061675WYETH AYERSTDiscontinued
ERYPARANDA062322WARNER CHILCOTTDiscontinued
ERYTHROMYCIN STEARATEANDA061461ANI PHARMSDiscontinued
BRISTAMYCINANDA061304BRISTOLDiscontinued
PFIZER-EANDA061791PFIZERDiscontinued
ERYTHROCIN STEARATEANDA060359AZURITYDiscontinued

FULL INTELLIGENCE ON ERYTHROMYCIN STEARATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →